The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

5 Apr 2022 16:35

RNS Number : 3743H
ABCAM PLC
05 April 2022
 

For immediate release

05 April 2022

ABCAM PLC

("Abcam" or the "Company")

Non-Executive Director Remuneration

Director/PDMR Shareholding Notification

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Peter Allen

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£ 14.36403

4,684

e)

Aggregated information

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.36403

4,684

£67,281.12

f)

Date of the transaction

04 April 2022

g)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Giles Kerr

2

Reason for the notification

a)

Position/status

Senior Independent Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£ 14.36403

1,719

e)

Aggregated information

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.36403

1,719

£24,691.77

f)

Date of the transaction

04 April 2022

g)

Place of the transaction

London Stock Exchange, AIM

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ms Mara Aspinall

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£ 14.36403

3,037

e)

Aggregated information

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.36403

3,037

£43,623.56

f)

Date of the transaction

04 April 2022

g)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Mark Capone

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£ 14.36403

1,584

e)

Aggregated information

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.36403

1,584

£22,752.62

f)

Date of the transaction

04 April 2022

g)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ms Bessie Lee

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£ 14.36403

1,019

e)

Aggregated information

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.36403

1,019

£14,636.95

f)

Date of the transaction

04 April 2022

g)

Place of the transaction

London Stock Exchange, AIM

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ms Sally Crawford

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares pursuant to individual fee arrangements

c)

Currency

GBP

d)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£ 14.36403

609

e)

Aggregated information

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.36403

609

£8,747.69

f)

Date of the transaction

04 April 2022

g)

Place of the transaction

London Stock Exchange, AIM

 

 

Forward-Looking Statements

 

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this announcement that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding award eligibility and LTIP issuance and value sufficiency under the laws of the United Kingdom, as well as statements that include the words "expect," "intend," "plan," "believe," "project," "forecast," "estimate," "may," "should," "anticipate" and similar statements of a future or forward-looking nature. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation: a regional or global health pandemic, including the novel coronavirus ("COVID-19"), which has adversely affected elements of our business, could severely affect our business, including due to impacts on our operations and supply chains; challenges in implementing our strategies for revenue growth in light of competitive challenges; developing new products and enhancing existing products, adapting to significant technological change and responding to the introduction of new products by competitors to remain competitive; failing to successfully identify or integrate acquired businesses or assets into our operations or fully recognize the anticipated benefits of businesses or assets that we acquire; if our customers discontinue or spend less on research, development, production or other scientific endeavours; and the important factors discussed under the caption "Risk Factors" in Abcam's prospectus pursuant to Rule 424(b) filed with the U.S. Securities and Exchange Commission ("SEC") on 22 October 2020, which is on file with the SEC and is available on the SEC website at www.sec.gov, as such factors may be updated from time to time in Abcam's other filings with the SEC. Any forward-looking statements contained in this announcement speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. Abcam disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEELFBLZLXBBL
Date   Source Headline
29th Oct 20212:42 pmRNSTotal Voting Rights
27th Oct 20217:00 amRNSCompletion of BioVision Acquisition
12th Oct 20214:46 pmRNSHolding(s) in Company
11th Oct 20214:21 pmRNSBlock listing Interim Review
6th Oct 202110:35 amRNSHolding(s) in Company
24th Sep 20214:03 pmRNSDirector/PDMR Shareholding
13th Sep 202112:00 pmRNSInterim results for the 6 and 12 month periods
1st Sep 20214:02 pmRNSTotal Voting Rights
1st Sep 202112:00 pmRNSTransition Report on 20-F and Notice of Results
17th Aug 20217:52 pmEQSThis is a test - Please ignore
13th Aug 20217:00 amRNSDirectorate Change
2nd Aug 202112:57 pmRNSTotal Voting Rights
2nd Aug 20217:00 amRNSAbcam to Acquire BioVision for $340 million
9th Jul 20212:34 pmRNSBlock listing Interim Review
1st Jul 20214:22 pmRNSTotal Voting Rights
1st Jul 20214:03 pmRNSResult of General Meeting
1st Jul 202112:00 pmRNSPre-Close Trading Update
2nd Jun 20219:54 amRNSTotal Voting Rights
2nd Jun 20218:30 amRNSNotice of Year End Change and General Meeting
19th May 20217:00 amRNSDirectorate Change
6th May 20217:00 amRNSTotal Voting Rights
1st Apr 20213:11 pmRNSTotal Voting Rights
12th Mar 20212:55 pmRNSDirector/PDMR Shareholding
11th Mar 202111:46 amRNSDirector/PDMR Shareholding - Replacement
10th Mar 20214:50 pmRNSDirector/PDMR Shareholding
8th Mar 202112:02 pmRNSInterim Results for 6 months ended 31 Dec 2020
1st Mar 20215:08 pmRNSTotal Voting Rights
26th Feb 20217:00 amRNSNotice of Results
17th Feb 202112:00 pmRNSAbcam presenting at the SVB Leerink Conference
4th Feb 20213:24 pmRNSDirector/PDMR Shareholding
1st Feb 20219:27 amRNSTotal Voting Rights
28th Jan 20217:00 amRNSDirectorate Change
14th Jan 20213:26 pmRNSHolding(s) in Company
11th Jan 202112:00 pmRNSHalf year trading update
4th Jan 202111:03 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSAbcam plc presenting at JPM Healthcare Conference
21st Dec 20207:00 amRNSNotification of Trading Update
17th Dec 20209:35 amRNSHolding(s) in Company
4th Dec 20202:32 pmRNSResult of AGM
1st Dec 20204:46 pmRNSTotal Voting Rights
4th Nov 202010:33 amRNSDirector/PDMR Shareholding
3rd Nov 20201:30 pmRNSAnnual Report, Impact Report and Notice of AGM
3rd Nov 20201:30 pmRNSConsultation on 2020 LTIP Awards
2nd Nov 202010:49 amRNSTotal Voting Rights
26th Oct 20203:45 pmRNSAbcam Announces Closing of Offering
23rd Oct 20207:00 amRNSExercise of Over-allotment Option
22nd Oct 20207:00 amRNSPricing of Offering on NASDAQ
19th Oct 202012:15 pmRNSOffering and Application to List on Nasdaq
5th Oct 20207:01 amRNSRegistration Statement for Proposed Offering Filed
5th Oct 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.